(Q37785243)

23 August 2017

title

Treatment of Helicobacter pylori infection: the past and the future (English)

1 reference

23 August 2017

Treatment of Helicobacter pylori infection: The past and the future (English)

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Helicobacter pylori infectious disease

6 July 2024

main subject

Helicobacter pylori

0 references

1 reference

1

Javier P. Gisbert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20816583

6 July 2024

author name string

José María Pajares

2

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20816583

6 July 2024

publication date

1 August 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0953620510001494?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

https://api.elsevier.com/content/article/PII:S0953620510001494?httpAccept=text/plain

6 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

European Journal of Internal Medicine

6 July 2024

published in

1 reference

23 August 2017

volume

21

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

357-359

1 reference

Evolution of Helicobacter pylori therapy from a meta-analytical perspective.

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

6 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference].

6 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Treatment of Helicobacter pylori infection

6 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

A report card to grade Helicobacter pylori therapy

6 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

6 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Helicobacter pylori "rescue" therapy after failure of two eradication treatments.

6 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

6 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials

6 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Seven-day therapy for Helicobacter pylori in the United States

6 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Evaluation of treatment regimens to cure Helicobacter pylori infection--a meta-analysis

6 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole

6 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond

6 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

H pylori antibiotic resistance: prevalence, importance, and advances in testing

6 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Ethical considerations of comparing sequential and traditional anti Helicobacter pylori therapy

6 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

6 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication

6 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

6 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity

6 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.

6 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan

6 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection

6 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Levofloxacin based regimens for the eradication of Helicobacter pylori

6 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Levofloxacin in first-line treatment of Helicobacter pylori infection

6 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

First-line triple therapy with levofloxacin for Helicobacter pylori eradication

6 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Levofloxacin, Amoxicillin, and Omeprazole as first-line triple therapy for Helicobacter pylori eradication

6 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole

6 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication

6 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.

6 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication

6 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Levofloxacin-based triple therapy for first-line Helicobacter pylori eradication treatment: a multi-central, randomized, controlled clinical study

6 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.

6 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Helicobacter pylori: resistencia a los antibióticos

6 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan

6 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium

6 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy

6 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study

6 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer

6 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis

6 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Sequential therapy for Helicobacter pylori eradication: a critical review

6 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Sequential regimens for Helicobacter pylori eradication

6 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

6 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment

6 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.

6 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

High eradication rates of Helicobacter pylori with a new sequential treatment

6 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

6 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.

6 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Sequential therapy regimen for Helicobacter pylori infection in children

6 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication

6 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Is there a role for sequential in sequential anti-H. pylori therapy?

6 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection

6 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

H. pylori treatment: new wine in old bottles?

6 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

Sequential therapy for Helicobacter pylori: time to consider making the switch?

6 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

New concepts of resistance in the treatment of Helicobacter pylori infections

6 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.009

6 July 2024

Identifiers

1 reference

23 August 2017

1 reference